What does Springworks Therapeutics, Inc. do?

Jun 22 2025 07:01 PM IST
share
Share Via
Springworks Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing treatments for rare diseases and cancer. As of March 2025, it reported net sales of $49 million and a net loss of $83 million, with a market cap of approximately $3.53 billion.
Overview:
Springworks Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on acquiring, developing, and commercializing medicines for patients suffering from rare diseases and cancer, operating within the Pharmaceuticals & Biotechnology industry and classified as a small-cap company.

Financial Snapshot:
Most recent Net Sales: 49 Million (Quarterly Results - Mar 2025)
Most recent Net Profit: -83 Million (Quarterly Results - Mar 2025)
Market cap: USD 3,530.85 Million (Small Cap)

Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 0.00%
Debt Equity: -0.69
Return on Equity: -59.66%
Price to Book: 8.46

Contact Details:
Address: 100 Washington Blvd, STAMFORD CT: 06902-9302
Tel: 1 203 8839490
Fax: 1 302 6555049
Website: https://www.springworkstx.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News